Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025)

Entera Bio (ENTX) recorded quarterly Asset Utilization Ratio of 0.0 in Q4 2025, down 62.4% on a QoQ basis from 0.01 in Q3 2025, and down 88.1% year-over-year from 0.02 in Q4 2024.

Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025) Analysis & Trends

Entera Bio has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.0 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 88.1% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 88.1% YoY) and the FY2025 annual result came in at 0.0, down 80.66% from the prior year.
  • Asset Utilization Ratio fell to 0.0 in Q4 2025, from 0.01 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.02 in Q4 2024 and troughed at 0.0 in Q3 2023.
  • A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2023 — Asset Utilization Ratio tumbled 91.05% — and 2024, when it surged 656.23%.
  • Tracing ENTX's Asset Utilization Ratio over 4 years: stood at 0.01 in 2022, then tumbled by 84.24% to 0.0 in 2023, then surged by 1334.66% to 0.02 in 2024, then tumbled by 88.1% to 0.0 in 2025.
  • Business Quant data shows ENTX's Asset Utilization Ratio at 0.0 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 0.55
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 1,422.00
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 0.47
9 Abivax 95.45 Bn 95.45 Bn - -
10 Entera Bio 57.79 Mn 53.65 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.02
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.02
Jun 30, 2022 0.02
Mar 31, 2022 0.02